Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04702373 · ClinicalTrials.gov registry record · Phase 3
Training in Exercise Activities and Motion for Growth (TEAM 4 Growth) RCT
A Phase 3 study of Congenital Heart Disease, sponsored by Carelon Research.
- Active
- Registry status
- Phase 3
- Development phase
- 144
- Enrollment target
- 10
- Study locations
NCT04702373 is a Phase 3 study of Congenital Heart Disease that is active but no longer recruiting, run by Carelon Research. The registered enrollment target is 144 participants, below the 472-participant average among 63 other Congenital Heart Disease trials with a reported enrollment target (69% lower). The trial reports 10 study locations across 10 states.
The verdict
NCT04702373, a Phase 3 study of Congenital Heart Disease, is active but no longer recruiting, sponsored by Carelon Research.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 3
- Development phase
- 144 participants
- Enrollment target
- 10
- Study locations
Study Summary
This is a Phase III randomized controlled trial of a passive ROM exercise program that will be performed in infants with HLHS and other single right ventricle anomalies following the Norwood procedure at PHN and Auxiliary Centers.
Conditions Studied
Interventions
- OTHER passive range of motion exercise therapy
Study Locations (10)
Georgia
- Children's Healthcare of Atlanta / Emory University - Atlanta
Indiana
- Riley Children's Hospital of Indiana - Indianapolis
Massachusetts
- Boston Children's Hospital - Boston
Michigan
- University of Michigan - Ann Arbor
Ohio
- Cincinnati Children's Hospital Medical Center - Cincinnati
Pennsylvania
- Children's Hospital of Philadelphia - Philadelphia
South Carolina
- Medical University of South Carolina - Charleston
Texas
- Texas Children's Hospital / Baylor - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 144 participants |
| Start Date | 2021-02-23 |
| Est. Completion | 2024-12-30 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04702373
The ClinicalTrials.gov registry entry for NCT04702373 describes a study currently listed as active not recruiting, categorized as Phase 3. The registered enrollment target is 144 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 472-participant average among 63 other Congenital Heart Disease trials with a reported enrollment target (69% lower). The listed sponsor is Carelon Research, which has 50 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Congenital Heart Disease appearing as the primary indexed condition, and to 1 intervention - of which passive range of motion exercise therapy is the first listed.
NCT04702373 reports 10 study locations spanning 10 distinct geographic areas - top geographies include Georgia, Indiana, Massachusetts.
Frequently Asked Questions
What is clinical trial NCT04702373 about?
NCT04702373 is a clinical study titled "Training in Exercise Activities and Motion for Growth (TEAM 4 Growth) RCT". This is a Phase III randomized controlled trial of a passive ROM exercise program that will be performed in infants with HLHS and other single right ventricle anomalies following the Norwood procedure at PHN and Auxiliary Centers.
What is the current status of trial NCT04702373?
This trial is currently active not recruiting. It is a Phase 3 study. The enrollment target is 144 participants. The study started on 2021-02-23. Estimated completion is 2024-12-30.
What conditions does trial NCT04702373 study?
This clinical trial studies the following conditions: Congenital Heart Disease.
What interventions are being tested in trial NCT04702373?
The interventions under investigation include: passive range of motion exercise therapy (OTHER).
Who is sponsoring clinical trial NCT04702373?
This trial is sponsored by Carelon Research, which has 50 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04702373 being conducted?
This trial has 10 study locations across Georgia, Indiana, Massachusetts, Michigan, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Congenital Heart Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effect of Sacubitril-Valsartan on Cardiac Structure and Function
RECRUITING · Phase 3
-
Acute Normovolemic Hemodilution in Complex Cardiac Surgery
COMPLETED · Phase 3
-
Fontan Fitness Trial
RECRUITING · NA
-
Fontan Associated Liver Disease and the Evaluation of Biomarkers for Disease Severity Assessment
RECRUITING
-
A Study of Invasive Hemodynamic for MACHD Registry
RECRUITING
-
Remote Monitoring in Pregnant Women With Congenital Heart Disease Using Wrist Wearables
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.